Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 ShuaiFuYuan Street, Dongcheng District, Beijing, 100730, China.
Central Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Ann Hematol. 2022 Jul;101(7):1447-1456. doi: 10.1007/s00277-022-04836-5. Epub 2022 May 9.
Immune thrombocytopenia (ITP) patients are at risk developing to systemic lupus erythematosus (SLE) in the future. Our study attempted to explore the potential risk factors for the development from ITP to SLE in Chinese children by statistical analysis. This study was a retrospective case-control study. Patients diagnosed with ITP and developed to SLE after the diagnosis of ITP were defined as the case group. The control group consisted of children with ITP but without developing to SLE was recruited with a ratio of 1:2. Besides univariable analysis, multivariable logistic regression was built to evaluate the potential risk factors. A total of 150 children was included with 50 in the case group and 100 in the control group. Median developing time from ITP to SLE was 34.5 [IQR 12.5, 58.75] months. ANA was found significantly different between the two groups in our study in the univariable analysis but not in the multivariable analysis (OR = 4.50, 95% CI 0.97 to 21.01). Age diagnosed ITP was positively associated with SLE (OR = 1.07 every 5 years, 95% CI 1.01 to 1.15) with alert point at 8 years old (sensitivity 0.82, specificity 0.60). A lower level of complement was also positively associated with SLE (OR = 8.33, 95% CI 1.62 to 42.91). A minimum 3-year of close follow-up for pediatric ITP patients was recommended to monitor the risk for developing SLE. Older age and hypocomplementemia were potential risk factors for the development from ITP to SLE.
免疫性血小板减少症(ITP)患者在未来发生系统性红斑狼疮(SLE)的风险增加。本研究试图通过统计分析探索中国儿童从 ITP 发展为 SLE 的潜在危险因素。本研究为回顾性病例对照研究。将诊断为 ITP 后发展为 SLE 的患者定义为病例组,将诊断为 ITP 但未发展为 SLE 的患者按 1:2 的比例纳入对照组。除单变量分析外,还建立多变量逻辑回归模型评估潜在危险因素。共纳入 150 例患儿,其中病例组 50 例,对照组 100 例。从 ITP 发展为 SLE 的中位时间为 34.5[IQR 12.5, 58.75]个月。在单变量分析中,ANA 在两组间差异有统计学意义,但在多变量分析中差异无统计学意义(OR=4.50,95%CI 0.9721.01)。ITP 诊断时的年龄与 SLE 显著相关(OR=1.07 每增加 5 岁,95%CI 1.011.15),年龄 8 岁为预警点(灵敏度 0.82,特异性 0.60)。补体水平降低也与 SLE 显著相关(OR=8.33,95%CI 1.62~42.91)。建议对儿科 ITP 患者进行至少 3 年的密切随访,以监测发生 SLE 的风险。年龄较大和低补体血症是从 ITP 发展为 SLE 的潜在危险因素。